Karen Lolans
- Molecular Medicine top 0.1%
- Infectious Diseases top 1%
- Molecular Biology top 10%
- Epidemiology top 5%
- Clinical Biochemistry top 0.2%
- Co-authors
- John P. QuinnMary K. HaydenRobert A. WeinsteinMaría Virginia VillegasL. Silvia Muñoz-PriceAdriana CorreaJaime Alberto LópezMichael Y. Lin
- Topics
- Antibiotic Resistance in Bacteria (38 papers)Antimicrobial Resistance in Staphylococcus (15 papers)Antibiotic Use and Resistance (14 papers)
- Partner nations
- United StatesColombiaUnited Kingdom
In The Last Decade
Karen Lolans
68 papers receiving 4.1k citations
Hit Papers
Peers
Comparison fields: 5 of 136
- Molecular Medicine 2.1k
- Infectious Diseases 1.5k
- Molecular Biology 1.1k
- Epidemiology 828
- Clinical Biochemistry 827
Countries citing papers authored by Karen Lolans
This map shows the geographic impact of Karen Lolans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Lolans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Lolans more than expected).
Fields of papers citing papers by Karen Lolans
This network shows the impact of papers produced by Karen Lolans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Lolans. The network helps show where Karen Lolans may publish in the future.
Co-authorship network of co-authors of Karen Lolans
This figure shows the co-authorship network connecting the top 25 collaborators of Karen Lolans. A scholar is included among the top collaborators of Karen Lolans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Lolans. Karen Lolans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 15 | |
| 3 | 32 | |
| 4 | 68 | |
| 5 | 3 | |
| 6 | 144 | |
| 7 | 40 | |
| 8 | 2 | |
| 9 | 136 | |
| 10 | 36 | |
| 11 | Targeted versus Universal Decolonization to Prevent ICU Infectionbreakdown → | 516 |
| 12 | 78 | |
| 13 | 38 | |
| 14 | 62 | |
| 15 | 50 | |
| 16 | 122 | |
| 17 | 235 | |
| 18 | 165 | |
| 19 | 98 | |
| 20 | 13 |
About Karen Lolans
Karen Lolans is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Endocrinology, having authored 71 papers that have together received 4.2k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (38 papers), Antimicrobial Resistance in Staphylococcus (15 papers) and Antibiotic Use and Resistance (14 papers). The work is most often cited by research in Molecular Medicine (2.1k citations), Applied Microbiology and Biotechnology (725 citations) and Endocrinology (793 citations). Karen Lolans has collaborated with scholars based in United States, Colombia and United Kingdom. Frequent co-authors include John P. Quinn, Mary K. Hayden, Robert A. Weinstein, María Virginia Villegas, L. Silvia Muñoz-Price, Adriana Correa, Jaime Alberto López, Michael Y. Lin, Juan Nicolás Kattán and Nicholas M. Moore. Their work appears in journals such as New England Journal of Medicine, Cell and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.